Using prenatal ultrasound to predict placental condition at birth.
Official title: Prenatal Sonographic Prediction of Placental Histology and Function
Run by Endeavor Health · NCT06022458 · Data updated 2026-11-12
This project will try to use ultrasound images during pregnancy to see if they can predict placental problems at delivery for people with fetal growth restriction or other pregnancy complications.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Women only |
| Enrollment | 320 (estimated) |
| Sponsor | Endeavor Health Academic / other |
| Locations | 1 site (Evanston, Illinois) |
| Status | Recruiting |
| Started | May 28, 2024 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT06022458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant people delivering at NorthShore with available prenatal ultrasound images and placental pathology, and for the prospective arm specifically those with singleton pregnancies and fetal growth restriction at 20–28 weeks or matched normal-growth pregnancies presenting for late-pregnancy ultrasound.
✕Probably not a fit
People with multiple gestations, major fetal anomalies, chronic hypertension or diabetes (for the unexposed arm), or those who will not deliver at NorthShore or lack suitable ultrasound images are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This two-phase observational project first analyzes archived prenatal ultrasounds and linked placental pathology from past deliveries to develop image-processing markers of placental injury. In the prospective phase, researchers will enroll pregnant people with singleton gestations who have fetal growth restriction at 20–28 weeks and a matched group with normal growth at 36–38 weeks to collect standardized ultrasounds and compare findings to placental histology at delivery. The team will search for ultrasound signatures associated with Amsterdam-classified placental lesions such as maternal or fetal vascular malperfusion and inflammation. The overall aim is to determine whether antepartum ultrasound can identify placental injury patterns that predict adverse outcomes.
Why it matters
Potential benefit: If successful, this could help clinicians detect placental injury before delivery and better target monitoring or interventions to reduce adverse pregnancy outcomes.
How similar studies have gone: Prior research has linked some ultrasound findings to placental problems, but applying automated image-processing to predict detailed placental histology before delivery is relatively new and not widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Retrospective Phase Inclusion criteria: * Patients with delivery in NorthShore University HealthSystem, * Ultrasound available within 4 weeks of delivery with adequate placental images * Placental pathology available Exclusion criteria: * Multiple gestation Prospective Phase Inclusion criteria * Exposed: Patients with singleton gestation with fetal growth restriction at 20-28 weeks with a plan to deliver at NorthShore Highland Park Hospital Evanston Hospital. Patients must have a first-trimester ultrasound (\<14 weeks) to confirm pregnancy dating available in the electronic medical record. * Unexposed: Patients who present for routine ultrasound evaluation at 36-38 weeks with normal fetal growth with a plan to deliver at NorthShore Highland Park Hospital or NorthShore Evanston Hospital. Exclusion criteria: * Exposed: Multiple gestation, major fetal anomaly * Unexposed: Multiple gestation, history of chronic hypertension, gestational or pregestational diabetes, major fetal anomaly antiphospholipid syndrome, known thrombophilia
Where it's running
-
NorthShore University HealthSystem
Evanston, Illinois, United States Recruiting
Study contacts
- Principal investigator: Sunitha Suresh — Endeavor Health
- Study coordinator: Sunitha Suresh
- Email: SSuresh@northshore.org
- Phone: 8475702860
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging
This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.
-
Womb Watch: using a smartphone app to detect fetal movements
This study tests a smartphone app to help pregnant people track fetal movements and see if it can better detect movement changes that might signal risk.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Leg vs Arm Ergometer Exercise for Gestational Diabetes
This study tests whether leg-ergometer exercise helps control blood sugar and reduce stress more than arm-ergometer exercise in pregnant people with gestational diabetes.
-
MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy
This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.